KISS1 and hypogonadotropic hypogonadism: To our knowledge, kisspeptin has not been studied in patients with PWS; however, since these patients have impaired hypothalamic function, obesity (often associated with diabetes), central hypogonadism, and GH deficiency, they would be expected to have decreased kisspeptin levels.